Imidazole-Based pH-Sensitive Convertible Liposomes for Anticancer Drug Delivery.
Ontology highlight
ABSTRACT: In efforts to enhance the activity of liposomal drugs against solid tumors, three novel lipids that carry imidazole-based headgroups of incremental basicity were prepared and incorporated into the membrane of PEGylated liposomes containing doxorubicin (DOX) to render pH-sensitive convertible liposomes (ICL). The imidazole lipids were designed to protonate and cluster with negatively charged phosphatidylethanolamine-polyethylene glycol when pH drops from 7.4 to 6.0, thereby triggering ICL in acidic tumor interstitium. Upon the drop of pH, ICL gained more positive surface charges, displayed lipid phase separation in TEM and DSC, and aggregated with cell membrane-mimetic model liposomes. The drop of pH also enhanced DOX release from ICL consisting of one of the imidazole lipids, sn-2-((2,3-di
SUBMITTER: Huang R
PROVIDER: S-EPMC8949415 | biostudies-literature | 2022 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA